Drugs Information:
Lamivudine
Basic Information
|
|
||
| ID | DDInter1019 | |
| Drug Type | small molecule | |
| Molecular Formula | C8H11N3O3S | |
| Molecular Weight | 229.256 | |
| CAS Number | 134678-17-4 | |
| Description | A reverse transcriptase inhibitor and zalcitabine analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat Human Immunodeficiency Virus Type 1 (HIV-1) and hepatitis B (HBV). | |
| ATC Classification | J05AR27 J05AR02 J05AR25 J05AR11 J05AR07 J05AR01 J05AR13 J05AR12 J05AR24 J05AR04 J05AR16 J05AR05 J05AF05 | |
| IUPAC Name | 4-amino-1-[(2R,5S)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-1,2-dihydropyrimidin-2-one | |
| InChI | JTEGQNOMFQHVDC-NKWVEPMBSA-N | |
| Canonical SMILES | NC1=NC(=O)N(C=C1)[C@@H]1CS[C@H](CO)O1 | |
| Useful Links | DrugBank ChEBI PubChem Substance KEGG Compound KEGG Drug ChemSpider BindingDB PharmGKB Therapeutic Targets Database Wikipedia ChEMBL ZINC | |
Interactions with
Lamivudine
Filter:
| Severity level | ID | Name | Mechanism | Detail |
|---|
Interactions with diseases
Filter:
| Severity level | Disease name | Text | References |
|---|
Interactions with foods
Filter:
| Severity level | Food name | Description | Management | Mechanism | References |
|---|
Interactions with compound preparation
| Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
|---|